Search

Now showing items 1-1 of 1

Radioimmunotherapy (Y-90-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab

Rossignol, J; Terriou, Louis; Robu, D; et al.
American journal of transplantation, 2015, 15, 1976-1981

Article dans une revue scientifique